Hyponatremia During Therapy With Amiodarone
Majed Odeh, MD;
Elad Schiff, MD;
Arie Oliven, MD
Arch Intern Med. 1999;159:2599-2600.
We describe an elderly woman who presented with significant hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) during therapy with amiodarone. The hyponatremia resolved after discontinuation of the drug and did not recur during a follow-up period of 6 months. Such an association has previously been reported only once in the medical literature. Since severe hyponatremia can produce significant neurologic damage and is associated with a high mortality rate, clinicians should be aware that this complication may occur during amiodarone therapy.
From the Department of Internal Medicine B, Bnai Zion Medical Center, and Technion Faculty of Medicine, Israel Institute of Technology, Haifa, Israel.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs
Miltiadous et al.
J CARDIOVASC PHARMACOL THER 2003;8:267-276.
ABSTRACT
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Induced by Amiodarone: A Report on Two Cases
Ikegami et al.
J CARDIOVASC PHARMACOL THER 2002;7:25-28.
ABSTRACT
Sustained hyposmotic stress induces cell death: apoptosis by defeat
Jackle et al.
Am. J. Physiol. Cell Physiol. 2001;281:C1716-C1726.
ABSTRACT
| FULL TEXT
|
